Titlebook: Serious Games: The Challenge; ITEC/CIP/T 2011: Joi Stefan Wannemacker,Sylke Vandercruysse,Geraldine C Conference proceedings 2012 Springer-

孵卵器

Marjoke Bakker,Marja van den Heuvel-Panhuizen,Sylvia van Borkulo,Alexander RobitzschIndia since August 2006, and is a potential anti-leishmanial drug that is being used in combination therapy. Amphotericin B, or its liposomal compound (AmBisome), remains the most potent drug with a cure rate of 98–100 % in all resistant cases of VL. Since 2015, single dose AmBisome (10 MKD) is bein

纤细

Charles-Frederik Hollemeersch,Bart Pieters,Peter Lambert,Rik Van de WalleIndia since August 2006, and is a potential anti-leishmanial drug that is being used in combination therapy. Amphotericin B, or its liposomal compound (AmBisome), remains the most potent drug with a cure rate of 98–100 % in all resistant cases of VL. Since 2015, single dose AmBisome (10 MKD) is bein

Pamphlet

Sylvia van Borkulo,Marja van den Heuvel-Panhuizen,Marjoke Bakker,Hanneke Loomansshown excellent performance on the Indian subcontinent, but the latter is preferred, as it is simpler to use. The proper implementation of these diagnostic strategies within the VL elimination program involves not only the procurement, training, and supervision of staff, but also quality control bot

oncologist

解脱

Pau Yanez,Xavier Maseffects and can cure more than 95% of VL patients with a single infusion, but it is very expensive. Hence, the Drugs for Neglected Diseases initiative (Geneva, Switzerland) in collaboration with the Indian Medical Research Council (Rajendra Memorial Research Institute, Patna, India) and the Kala-Aza

Host142

Jan-Henk Annema,Yorick Poels,Bieke Zaman,Frederik Cornillieeffects and can cure more than 95% of VL patients with a single infusion, but it is very expensive. Hence, the Drugs for Neglected Diseases initiative (Geneva, Switzerland) in collaboration with the Indian Medical Research Council (Rajendra Memorial Research Institute, Patna, India) and the Kala-Aza

Toxoid-Vaccines

Amorous

Itinerant

nocturia